VP, Bioanalytical Development
- Expertise
- Services
- Solutions
- About Us
- Resources
Expertise
Services
Solutions
About Us
About Us- Overview
- Leadership
- Facility and Equipment
- Quality and Compliance
- Therapeutic Areas
- Why Us?
- Values
- Process
- Partners
- Careers
Business Development Associate
Sr. Scientist – Cell Based Assay
GLP Quality Assurance Manager
Sr. Scientist, ELISA Immunoassay Bioanalysis
Sr. Scientist, LC-MS/MS Bioanalysis
Associate Scientist, Central Laboratory Services
Sr. Scientist - Pharmacokinetics (PK)
Content Manager, Scientific and Regulatory Writing
Resources
Outstanding Method Development/Transfer And Validation CRO Lab Services!
- Tailor-Made, High-Value Method Development And Assay Troubleshooting Services For Biotech
- GLP Method Validation Services At Industry-Leading Turnaround
- Preclinical/Clinical Method Transfer For Rapid Drug & Biomarker Sample Analysis
- FDA Audited Bioanalytical CRO Lab Services For Your LC-MS Analysis, ELISA, Luminex, MSD, Or RT-qPCR Assay
Regulated And Inspected By:
Contact A Scientist For Method Development And Validation
We Will Respond Within 1 Business Day
Click below for answers to your Method Development, Validation, and Transfer questions -
Ask Us About Your Study
Our scientists use effective method development validation techniques to identify, separate, and quantify drugs and metabolites in biological fluids. A Method Development Validation Lab ensures that all processes adhere to strict quality standards for preclinical and clinical trials. Here’s how we can support your study:
- Identify and separate drugs and metabolites in biological matrices.
- Apply method validation techniques for accuracy and reproducibility.
- Ensure regulatory compliance throughout preclinical and clinical trials.
- Offer comprehensive solutions for drug testing and quantification.
What Is Method Development? How Is It Different From Method Transfer?
Method Development is the process of selecting and optimizing analytical methods to measure specific attributes of a drug substance or drug product. This process ensures that methods provide accurate, reliable, and reproducible results. Key considerations include sample preparation, instrument settings, and analyte stability. Analytical method development and validation plays a critical role in maintaining a drug’s identity, purity, potency, and stability throughout its lifecycle.
A Method Development Validation Lab is essential in this process to ensure the accuracy and reliability of the methods developed. The lab specializes in creating optimized methods for drug testing, ensuring compliance with regulatory standards.
Method Transfer, on the other hand, refers to the process of transferring an analytical method from one laboratory to another or from one piece of equipment to another. This ensures consistency across different labs or locations, especially when multiple testing sites are involved in drug development.
Key Differences:
- Method Development focuses on creating and optimizing a method for specific drug attributes.
- Method Transfer ensures the method can be successfully implemented across different labs or equipment while maintaining accuracy and consistency.
Sponsors Love Our Bioanalytical Laboratory Services For Top Quality And Industry Leading Turnaround
Connect With Us For A Reference Call With Them!
NorthEast BioLab is a responsive, collaborative, and reliable partner
We trust NorthEast BioLab to design and execute streamlined, impactful bioanalytical projects
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
“NorthEast BioLab goes the extra mile. We look forward to more meaningful collaborations.”
NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.
NorthEast BioLab’s scientists deliver high-quality data on time and within budget
Tackle Your Method Development/Transfer And Validation
What Is Method Validation? How Is It Different From Partial Validation And Cross-Validation?
Method Validation confirms that an analytical method is suitable for its intended use and produces reliable results over time. It follows guidelines from regulatory bodies such as the FDA and ICH, ensuring that methods comply with regulatory standards. This process evaluates key parameters such as specificity, accuracy, precision, and sensitivity.
A Method Development Validation Lab ensures that method validation is executed with precision, providing sponsors confidence in the methods used for drug testing. Additionally, analytical method development and validation procedures ensure that the process adheres to all necessary guidelines for quality and compliance.
Partial Validation is used when modifications are made to a previously validated method. It covers only the modified aspects, ensuring that the changes do not affect the reliability of the results.
Cross-validation involves comparing results from two or more analytical methods to ensure consistency across different laboratories, instruments, or matrices. It is a crucial part of method transfer and ensures the method’s robustness.
Key Differences:
- Method Validation is a comprehensive evaluation ensuring an analytical method is reliable for its intended use.
- Partial Validation focuses on confirming specific modifications made to a previously validated method.
- Cross-validation ensures the method produces consistent results across different labs or instruments.
Registered And Inspected By Various Regulatory Agencies
Don’t Wait, Start Your Method Development/Transfer And Validation
What Are the Key Steps for Method Development And Validation?
We follow these key steps to ensure successful analytical method development and validation:
-
Define the Method Objectives:
Establish the critical quality attributes (CQAs) of the drug and the acceptance criteria for the method.
-
Conduct a Literature Review:
A comprehensive review of scientific literature and regulatory standards to set a baseline.
-
Develop a Method Plan:
Select reference standards, instrumentation, and experimental design.
-
Optimize the Method:
Ensure sensitivity and robustness to meet performance requirements.
-
Validate the Method:
Rigorous testing of linearity, range, LOD, and LOQ to ensure the method is reliable.
Analytical method development and validation procedures are critical to ensure that selected methods can handle different drug properties and meet regulatory requirements with precision and accuracy. Working with a Method Development Validation Lab ensures these steps are followed meticulously, ensuring compliance with all regulatory standards.
The Basics of Bioanalysis
Bioanalysis is an essential tool in drug discovery and development for determining the concentration of drugs and their metabolites in biological matrices. Bioanalytical methods such as LC-MS and ELISA are routinely used to support pharmacokinetics and drug metabolism studies. Precise quantitation of drug and metabolite concentrations is crucial for understanding pharmacokinetics, drug-drug interactions, and safety profiles…..
What Is Sample Analysis Protocol for GLP Studies?
Sample analysis for Good Laboratory Practice (GLP) studies is a critical component of bioanalysis. This phase involves developing protocols, sample handling, and analysis under strict regulatory guidelines. Depending on the development phase, sample analysis can be performed under R&D or cGMP conditions. Our laboratory employs high-precision instrumentation, such as LC-MS and ELISA, to ensure reliable and reproducible results throughout drug development.
In GLP studies, the following aspects are crucial for the sample analysis protocol:
- Prepare Calibration Standards and Quality Controls for accurate quantification.
- Perform Test Runs to ensure method accuracy before large-scale sample analysis.
- Analyze Samples under tightly controlled conditions, following all GLP regulations.
- Ensure the Stability of Drugs and Biomarkers in biological matrices during sample handling, analysis, and long-term storage at various time points.
Sample Analysis & Final Validation:
The final step in the method development validation process involves developing a protocol and conducting sample analysis. Depending on the development phase, this can be conducted under R&D or cGMP conditions. Our lab employs high-precision instrumentation, such as LC-MS and ELISA, to ensure reliable and reproducible results throughout drug development.
Working with a Method Development Validation Lab ensures that each phase of sample analysis and validation is conducted in line with regulatory requirements, guaranteeing reliable and consistent results across the board. Additionally, analytical method development and validation ensure that all methods used in drug testing are robust, accurate, and reproducible.
Trust Our Method Development/Transfer And Validation Lab CRO Services.
Related FAQs
Answers to additional Method Development, Validation And Transfer questions popular among our potential clients.
